Welcome to the Vaccine section

All the following vaccines were developed to treat and protect from a wide range of infectious diseases in the paediatric, travel and endemic fields. Produced in Sweden and others parts of Europe, these vaccines follow strict EMA regulations. Additional products are added to this list on a regular basis, so be sure to come back and check again.
If you have specific requests or looking for vaccines that are not listed, please send us a Quote or Request at the following address : This email address is being protected from spambots. You need JavaScript enabled to view it.


  Quinvaxem® Quinvaxem® fully liquid pentavalent (five-in-one) vaccine protects infants against five deadly childhood infections: diphtheria (D), tetanus (T), pertussis (P, whooping cough), hepatitis B (HepB), and Haemophilus influenzae type b (Hib).
  Hepavax-Gene® Hepavax-Gene® is a recombinant hepatitis B vaccine. Its immunogenic component, recombinant hepatitis B surface antigen (HbsAg), is produced in modified yeast using Crucell's proprietary Hansenula polymorpha expression system. It is one of the WHO's pre-qualified vaccines for active immunization against hepatitis B virus.
  Epaxal® Junior Epaxal® Junior induces protective antibody levels within 10 days of primary vaccination and provides seroprotection for at least 20 years following the second (booster) dose. It can be fitted into the regular immunization schedule for babies.
Travel and endemic
  Epaxal® Epaxal® is the only aluminium-free hepatitis A vaccine on the market, offering significant advantages in terms of tolerability.
  Vivotif® Vivotif® is a live attenuated typhoid fever vaccine for oral administration. It is the only oral vaccine indicated for use against Salmonella typhi, the most prevalent of the typhoid fever-causing bacteria. The vaccine is indicated for adults and children over the age of five and has an excellent track record for safety, having been on the market for more than 20 years.
  Dukoral® Dukoral® is a drinkable vaccine with a documented protective effect against diarrhea caused by cholera, as well as traveler's diarrhea in Canada. The vaccine stimulates a protective immune response in the gut and has a demonstrated protective efficacy against cholera of approximately 84-86%.
  Inflexal® V Inflexal® V (Virosomal adjuvanted influenza vaccine) is the only adjuvanted Flu vaccine licensed for all age groups (up from 6 months). The vaccine's antigen composition follows yearly WHO recommendations.